T1	Outcomes 1081 1111	non-inferiority of lumiracoxib
T2	Outcomes 1183 1218	1-year retention on treatment rate.
T3	Outcomes 1256 1454	OA pain in the target joint, patient's and physician's global assessments of disease activity, Short Arthritis assessment Scale (SAS) total score, rescue medication use, and safety and tolerability.
T4	Outcomes 1463 1478	Retention rates
T5	Outcomes 1660 1669	retention
T6	Outcomes 2033 2043	tolerated.
T7	Outcomes 2160 2169	tolerated
